Cargando…

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is the most malignant glioma with a high death rate. N6-methyladenosine (m6A) RNA methylation plays an increasingly important role in tumors. The current study aimed to determine the function of the regulators of m6A RNA methylation in GBM. We evaluated the difference,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Li-chong, Chen, Shu-hui, Shen, Xiao-li, Li, Dang-chi, Liu, Hai-yun, Ji, Yu-long, Li, Min, Yu, Kai, Yang, Huan, Chen, Jun-Jun, Qin, Chong-zhen, Luo, Ming-ming, Lin, Qian-xia, Lv, Qiao-li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578363/ https://www.ncbi.nlm.nih.gov/pubmed/33134160 http://dx.doi.org/10.3389/fonc.2020.536875

Ejemplares similares

HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021)

Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival
por: Zhang, Miao, et al.
Publicado: (2019)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme
por: Xia, Xiangping, et al.
Publicado: (2019)

Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
por: Hou, Aiwu, et al.
Publicado: (2016)

HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells
por: Gu, Zhuoyu, et al.
Publicado: (2022)

Contribution of the Testosterone Androgen Receptor–PARD3B Signaling Axis to Tumorigenesis and Malignance of Glioblastoma Multiforme through Stimulating Cell Proliferation and Colony Formation
por: Yang, Jr-Di, et al.
Publicado: (2022)

Differential Expression of Circular RNAs in Glioblastoma Multiforme and Its Correlation with Prognosis()
por: Zhu, Junle, et al.
Publicado: (2017)

Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme
por: Li, Yanxin, et al.
Publicado: (2021)

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
por: Dong, Jiawei, et al.
Publicado: (2022)

Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide
por: Feng, Shao-Wei, et al.
Publicado: (2023)

Genome-Wide Methylation Analyses in Glioblastoma Multiforme
por: Lai, Rose K., et al.
Publicado: (2014)

Proteogenomic characterization and integrative analysis of glioblastoma multiforme
por: Song, Ying-Chun, et al.
Publicado: (2017)

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson's Disease
por: Quan, Wei, et al.
Publicado: (2021)

MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme
por: Della Monica, Rosa, et al.
Publicado: (2022)

Glioblastoma multiforme with vertebral metastases: A case report
por: Liu, Hongyu, et al.
Publicado: (2021)

CIC protein instability contributes to tumorigenesis in glioblastoma
por: Bunda, Severa, et al.
Publicado: (2019)

Prediction of BRAF mutation status in glioblastoma multiforme by preoperative ring enhancement appearances on MRI
por: Cai, Xiaomin, et al.
Publicado: (2022)

Cytosine methylation of mature microRNAs inhibits their functions and is associated with poor prognosis in glioblastoma multiforme
por: Cheray, Mathilde, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Glioblastoma multiforme: Diagnosis, treatment, and invasion
por: Li, Jiawei, et al.
Publicado: (2023)

MRI Manifestions Correlate with Survival of Glioblastoma Multiforme Patients
por: Li, Wen-bin, et al.
Publicado: (2012)

DNA methylation profiling identifies potentially significant epigenetically-regulated genes in glioblastoma multiforme
por: Kan, Shifeng, et al.
Publicado: (2019)

Network pharmacological analysis of active components of Xiaoliu decoction in the treatment of glioblastoma multiforme
por: Wu, Ji, et al.
Publicado: (2022)

Identification of T‐cell exhaustion‐related gene signature for predicting prognosis in glioblastoma multiforme
por: Liu, Yue‐hui, et al.
Publicado: (2023)

A Multi-Element Expression Score Is A Prognostic Factor In Glioblastoma Multiforme
por: Li, Jun-Qi, et al.
Publicado: (2019)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

Development of a novel angiogenesis-related lncRNA signature to predict the prognosis and immunotherapy of glioblastoma multiforme
por: Zhang, Binbin, et al.
Publicado: (2022)

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
por: Chen, Anjing, et al.
Publicado: (2022)

Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment
por: Shen, Chiung-Chyi, et al.
Publicado: (2020)

miR-135b Contributes to the Radioresistance by Targeting GSK3β in Human Glioblastoma Multiforme Cells
por: Xiao, Songhua, et al.
Publicado: (2014)

miR-340 suppresses glioblastoma multiforme
por: Huang, Daquan, et al.
Publicado: (2015)

Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme
por: Kasl, Rebecca A., et al.
Publicado: (2016)

Regulatory pattern of abnormal promoter CpG island methylation in the glioblastoma multiforme classification
por: Wang, Rendong, et al.
Publicado: (2022)

Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
por: Cai, Xiaomin, et al.
Publicado: (2022)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma
por: Yu, Kai, et al.
Publicado: (2021)

The availability of the embryonic TGF-β protein Nodal is dynamically regulated during glioblastoma multiforme tumorigenesis
por: Oliveira-Nunes, Maria Cecília, et al.
Publicado: (2016)

PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
por: Qiao, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ukhiiq6jlq064ksr2n0qvm5bld